| Year |
Citation |
Score |
| 1995 |
Tuinier S, Verhoeven WM, van Praag HM. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. International Clinical Psychopharmacology. 10: 147-56. PMID 8675967 |
0.505 |
|
| 1992 |
Kahn RS, van Praag HM. Panic disorder: a biological perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 1-20. PMID 1638169 DOI: 10.1016/0924-977X(92)90031-3 |
0.333 |
|
| 1992 |
Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 106: 388-90. PMID 1533289 DOI: 10.1007/BF02245423 |
0.302 |
|
| 1992 |
Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43: 65-76. PMID 1438618 DOI: 10.1016/0165-1781(92)90142-P |
0.401 |
|
| 1991 |
Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 37: 271-9. PMID 1891509 DOI: 10.1016/0165-1781(91)90063-U |
0.361 |
|
| 1991 |
Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry. 30: 770-8. PMID 1751620 DOI: 10.1016/0006-3223(91)90233-C |
0.349 |
|
| 1991 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37: 25-34. PMID 1650487 DOI: 10.1016/0165-1781(91)90103-V |
0.301 |
|
| 1990 |
Kahn RS, van Praag HM. Panic disorder: a presynaptic serotonin defect? Psychiatry Research. 31: 209-10. PMID 2326399 DOI: 10.1016/0165-1781(90)90123-M |
0.304 |
|
| 1990 |
Wetzler S, Kahn RS, Cahn W, van Praag HM, Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Research. 31: 179-92. PMID 2326397 DOI: 10.1016/0165-1781(90)90120-T |
0.351 |
|
| 1990 |
Van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences. 600: 501-10. PMID 2252329 |
0.356 |
|
| 1990 |
Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Research. 33: 189-98. PMID 2243896 DOI: 10.1016/0165-1781(90)90073-E |
0.354 |
|
| 1990 |
Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28: 358-62. PMID 2204434 DOI: 10.1016/0006-3223(90)90663-M |
0.382 |
|
| 1990 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology. 100: 339-44. PMID 2156278 DOI: 10.1007/BF02244603 |
0.309 |
|
| 1990 |
van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. The British Journal of Psychiatry : the Journal of Mental Science. 157: 723-34. PMID 1980627 |
0.35 |
|
| 1988 |
Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23: 189-208. PMID 3275471 DOI: 10.1016/0006-3223(88)90091-1 |
0.37 |
|
| 1988 |
Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research. 25: 101-4. PMID 3217461 DOI: 10.1016/0165-1781(88)90163-1 |
0.389 |
|
| 1988 |
van Praag HM, Kahn RS. L-5-hydroxytryptophan in depression and anxiety. Schweizerische Rundschau Fã¼R Medizin Praxis = Revue Suisse De Mã©Decine Praxis. 77: 40-6. PMID 3055148 |
0.358 |
|
| 1988 |
Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 96: 360-4. PMID 2906153 DOI: 10.1007/BF00216062 |
0.367 |
|
| 1987 |
van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders. 13: 1-8. PMID 2959695 DOI: 10.1016/0165-0327(87)90067-X |
0.336 |
|
| 1984 |
Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4 |
0.615 |
|
| 1981 |
Verhoeven WM, van Praag HM, de Jong JT. Use of naloxone in schizophrenic psychoses and manic syndromes. Neuropsychobiology. 7: 159-68. PMID 7231653 DOI: 10.1159/000117845 |
0.478 |
|
| 1981 |
van Praag HM, Verhoeven WM. Neuropeptides. A new dimension in biological psychiatry. Progress in Brain Research. 53: 229-52. PMID 7005944 DOI: 10.1016/S0079-6123(08)60067-9 |
0.454 |
|
| 1981 |
Van Praag HM, Verhoeven WM. Endorphin research in schizophrenic psychoses. Comprehensive Psychiatry. 22: 135-46. PMID 6260424 DOI: 10.1016/0010-440X(81)90061-4 |
0.44 |
|
| 1977 |
Westenberg HG, Drenth BF, de Zeeuw RA, de Cuyper H, van Praag HM, Korf J. Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. Journal of Chromatography. 142: 725-33. PMID 914945 |
0.426 |
|
| 1977 |
Westerink BH, Lejeune B, Korf J, Van Praag HM. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. European Journal of Pharmacology. 42: 179-90. PMID 844497 |
0.499 |
|
| 1977 |
Westenberg HG, De Zeeuw RA, De Cuyper H, Van Praag HM, Korf J. Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography. Postgraduate Medical Journal. 53: 124-30. PMID 600889 |
0.417 |
|
| 1977 |
Van der Poel FW, Van Praag HM, Korf J. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology. 52: 35-40. PMID 403555 |
0.459 |
|
| 1977 |
Van Scheyen JD, Van Praag HM, Korf J. Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique. British Journal of Clinical Pharmacology. 4: 179S-184S. PMID 334221 |
0.536 |
|
| 1976 |
van Praag HM, Korf J, Lequin RM. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin. Psychopharmacology Communications. 2: 369-78. PMID 1088302 |
0.488 |
|
| 1976 |
Van Praag HM, Korf J, Dols LC. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity. The British Journal of Psychiatry : the Journal of Mental Science. 129: 547-55. PMID 1000139 |
0.479 |
|
| 1976 |
Van Praag HM, Korf J. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics. The American Journal of Psychiatry. 133: 1171-7. PMID 970488 |
0.499 |
|
| 1976 |
Korf J, Sebens JB, Venema K, van Praag HM. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester. Research Communications in Chemical Pathology and Pharmacology. 15: 171-82. PMID 968174 |
0.489 |
|
| 1976 |
van Praag HM, Korf J. 4-chloroamphetamines. Chance and trend in the development of new antidepressants. Psychopharmacology Bulletin. 12: 64-74. PMID 785522 |
0.467 |
|
| 1975 |
van Praag HM, Korf J. Central monoamine deficiency in depressions: causative of secondary phenomenon? Pharmakopsychiatrie, Neuro-Psychopharmakologie. 8: 322-6. PMID 1085937 DOI: 10.1055/s-0028-1094463 |
0.532 |
|
| 1975 |
van Praag HM, Korf J. Biochemical research into psychosis. Acta Psychiatrica Scandinavica. 51: 268-84. PMID 238363 |
0.516 |
|
| 1975 |
Van Praag HM, Korf J. Neuroleptics, catecholamines, and psychoses: a study of their interrelations. The American Journal of Psychiatry. 132: 593-7. PMID 235848 |
0.493 |
|
| 1974 |
van Praag HM, Korf J. Serotonin metabolism in depression: clinical application of the probenecid test. International Pharmacopsychiatry. 9: 35-51. PMID 4599325 |
0.545 |
|
| 1974 |
van Praag HM, Korf J. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test. The Journal of Nervous and Mental Disease. 158: 331-7. PMID 4596091 |
0.467 |
|
| 1974 |
Korf J, van Praag HM, Schut D, Nienhuis RJ, Lakke JP. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy. European Neurology. 12: 340-50. PMID 4448192 DOI: 10.1159/000114631 |
0.45 |
|
| 1973 |
van Praag HM, Flentge F, Korf J, Dols LC, Schut T. The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia. 33: 141-51. PMID 4775879 |
0.506 |
|
| 1973 |
van Praag HM, Korf J, Schut D. Cerebral monoamines and depression. An investigation with the Probenecid technique. Archives of General Psychiatry. 28: 827-31. PMID 4707990 |
0.497 |
|
| 1973 |
Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM. The probenecid test in Parkinson's disease. Psychiatria, Neurologia, Neurochirurgia. 76: 139-46. PMID 4700931 |
0.435 |
|
| 1973 |
van Praag HM, Korf J. 4-Chloramphetamines. Chance and trend in the development of new antidepressants. The Journal of Clinical Pharmacology and New Drugs. 13: 3-14. PMID 4566121 |
0.465 |
|
| 1973 |
Lakke JP, Korf J, van Praag HM, Minderhoud JM, Schut T. Clinical significance of probenecid test. Lancet. 1: 614-5. PMID 4120687 DOI: 10.1016/S0140-6736(73)90770-8 |
0.437 |
|
| 1972 |
Korf J, Van Praag HM, Sebens JB. Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. Brain Research. 42: 239-42. PMID 5047195 |
0.443 |
|
| 1972 |
van Praag HM, Korf J, Dols LC, Schut T. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia. 25: 14-21. PMID 4556909 |
0.47 |
|
| 1972 |
Lakke JP, Korf J, Van Praag HM, Schut T. [Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]. Nature: New Biology. 236: 208-9. PMID 4553111 |
0.456 |
|
| 1972 |
Korf J, van Praag HM. Action of p-chloroamphetamine on cerebral serotonin metabolism: an hypothesis. Neuropharmacology. 11: 141-4. PMID 4110561 |
0.487 |
|
| 1971 |
Korf J, van Praag HM. Retarded depression and the dopamine metabolism. Psychopharmacologia. 19: 199-203. PMID 5565740 |
0.539 |
|
| 1971 |
Korf J, van Praag HM. Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacologia. 19: 148-52. PMID 5565735 |
0.533 |
|
| 1971 |
van Praag HM, Korf J. [Are disturbances in the central metabolism of dopamine specific for Parkinson's syndrome?]. Nederlands Tijdschrift Voor Geneeskunde. 115: 514-5. PMID 5546941 |
0.481 |
|
| 1971 |
Korf J, van Praag HM, Sebens JB. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochemical Pharmacology. 20: 659-68. PMID 5150161 |
0.451 |
|
| 1971 |
van Praag HM, Korf J. [Current developments in the field of antidepressive agents]. Nederlands Tijdschrift Voor Geneeskunde. 115: 1963-70. PMID 5148103 |
0.437 |
|
| 1971 |
Korf J, Van Praag HM. Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Research. 35: 221-30. PMID 5134227 |
0.47 |
|
| 1971 |
van Praag HM, Korf J. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biological Psychiatry. 3: 105-12. PMID 5089909 |
0.532 |
|
| 1971 |
Lakke JP, Korf J, van Praag HM. Predicting response to levodopa. Lancet. 2: 164-5. PMID 4104491 |
0.425 |
|
| 1970 |
van Praag HM, Korf J, Puite J. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature. 225: 1259-60. PMID 5435360 |
0.515 |
|
| 1970 |
van Woudenberg F, Wiegman T, van Praag HM, Korf J. Investigation of the influence of p-chloro-N-methamphetamine on the human metabolism of 5-hydroxytryptamine with high voltage electrophoresis and liquid scintillation counting. Clinica Chimica Acta; International Journal of Clinical Chemistry. 27: 313-5. PMID 5417229 |
0.458 |
|
| 1970 |
Korf J, van Praag HM. The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia. 18: 129-32. PMID 4943187 |
0.535 |
|
| 1970 |
van Praag HM, Korf J, van Woudenberg F. Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man. Psychopharmacologia. 18: 412-20. PMID 4923523 |
0.453 |
|
| 1970 |
van Praag HM, Korf J. L-tryptophan in depression. Lancet. 2: 612. PMID 4195577 |
0.497 |
|
| 1969 |
van Praag HM, Korf J, van Woudenberg F, Kits TP. An attempt at indirect evaluation of the noradrenaline hypothesis. Psychiatria, Neurologia, Neurochirurgia. 72: 181-7. PMID 5792058 |
0.443 |
|
| 1968 |
van Praag HM, Korf J, van Woudenberg F, Kits TP. Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-chloro-N-methylamphetamine). Psychopharmacologia. 13: 145-60. PMID 5678577 |
0.49 |
|
| Show low-probability matches. |
